Pharmaceutical

New Drug Targets Enter Clinical Trials – OMA1, CAPN2, BTM-3566 & AMX-0114 Discover groundbreaking drug targets OMA1 and CAPN2, along with promising therapies BTM-3566 and AMX-0114, entering clinical trials. Learn how they could revolutionize treatments for cancer, metabolic disorders, and neurological diseases.
9 Promising New Drugs to Watch in 2025 Market Trend Discover 9 groundbreaking new drugs to watch in 2025, from cancer and neurodegenerative treatments to obesity and cardiovascular breakthroughs. Stay updated on the latest advancements in precision medicine, CRISPR, AI-driven drug development, and innovative therapies.
Top 10 Pharmaceutical Giants' R&D Investments in 2024 Market Trend Merck Johnson & Johnson Roche AstraZeneca AbbVie Eli Lilly Novartis In 2024, pharmaceutical giants face a quiet battle over innovation and efficiency. From Merck’s 41% R&D drop to AbbVie’s bold growth, their strategies and investments reveal shifting power in the industry. A glimpse into the future of drug development.
Top 16 Best-Selling New Drugs Worldwide in 2024 Market Trend GSK Sanofi AstraZeneca Novartis Amgen Roche Discover the top 16 best-selling new drugs of 2024, featuring innovative FIC and BIC molecules, breakthrough therapies across various fields, and products that stood out due to unique development strategies.
2024 Global CAR-T Sales Performance CAR-T Market Trend Gilead Johnson & Johnson Bristol Myers Squibb Novartis Discover the sales performance of CAR-T therapies in 2024, including Kymriah, Yescarta, Breyanzi, and more. Explore trends, growth, and challenges in the CAR-T cell therapy market across the US and beyond.
Top 10 Global Pharmaceutical Giants in Oncology Business for 2024 Oncology Market Trend Merck Roche AstraZeneca Johnson & Johnson Discover the top 10 pharmaceutical giants leading the oncology industry in 2024. From Merck's dominance with Keytruda to AstraZeneca's rise, these companies are making strides in cancer treatment, innovation, and growth.
Ionis Pharmaceuticals 2024 Performance Report Financial statements Ionis Pharmaceuticals Ionis Pharmaceuticals reported a 2024 revenue decline of 11%, with a $475 million operating loss. The report highlights product sales from Spinraza, Wainua, Qalsody, and others, alongside its cash reserves and 2025 guidance.
Top 10 Global Pharmaceutical Giants in Autoimmune Business in 2024 Autoimmune Market Trend Pfizer Eli Lilly Takeda Amgen Roche Novartis The autoimmune sector saw explosive growth in 2024, with mergers and acquisitions skyrocketing by 150%. Giants like AbbVie, J&J, and Eli Lilly are reshaping the landscape. Explore the Top 10 revenue rankings in the autoimmune business and future trends.
Hengrui Pharmaceutical ADC Drug Overview Hengrui ADC Hengrui has emerged as a leading force in ADC drug development, with a deep pipeline of 12 ADC drugs in clinical trials. Its proprietary HRMAP® platform and strategic innovations in targeting toxins and drug conjugation offer promising breakthroughs.
Top 10 Indian Pharmaceutical Companies of 2025 Market Trend Lupin Discover the top 10 Indian pharmaceutical companies in 2025, leading the global market with high-quality generics, innovative drug development, and strong exports. Explore key industry trends, revenue insights, and future growth opportunities in India's pharma sector.

< Pre 1...56 57 585960 61 62...87 Next >

Articles Archives

Hot Articles

Related Exhibition

All Categories

Agri & Industry Cosmetic Food History Laboratory

HOT Topics

Hot Articles